Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment

Despite treatment of patients with metastatic colorectal cancer (mCRC) with bevacizumab plus chemotherapy, response rates are modest and there are no biomarkers available that will predict response. The aim of this study was to assess if markers associated with three interconnected cancer-associated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Noonan, Sinead A., Morrissey, Maria E., Martin, Petra, Biniecka, Monika, Ó'Meachair, Shane, Maguire, Aoife, Tosetto, Miriam, Nolan, Blathnaid, Hyland, John, Sheahan, Kieran, O'Donoghue, Diarmuid, Mulcahy, Hugh, Fennelly, David, O'Sullivan, Jacintha
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828217/
https://ncbi.nlm.nih.gov/pubmed/29535825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24276
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados